CIK 0001478320
- Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- Operating
- EIN
- 270907024
- Phone
- +1 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- 4 Open-market sale Director sold 20,000 shares at $57.80 ($1,156,000)
- 4 Open-market sale Chief Business Development Off sold 6,771 shares at an average $57.62 ($390,143)
- 4 Open-market sale President sold 15,000 shares at $56.23 ($843,450)
- 4 Open-market sale SVP and General Counsel sold 2,812 shares at an average $55.53 ($156,138)
- 4 Open-market sale President sold 29,675 shares at an average $56.99 ($1,691,056)
- 4 Open-market sale President sold 30,000 shares at an average $57.58 ($1,727,410)
- 4 Open-market sale President sold 15,000 shares at an average $62.29 ($934,365)
- 4 Open-market sale President sold 30,000 shares at an average $61.49 ($1,844,636)
- 4 Grant or award Director acquired 1,504 shares (grant or award)
- 4 Grant or award Director acquired 1,504 shares (grant or award)
- 4 Open-market sale Chief People Officer sold 2,000 shares at $65.45 ($130,900)
- 4 Open-market sale President sold 30,000 shares at an average $65.61 ($1,968,432)
- 4 Open-market sale SVP and General Counsel sold 16,250 shares at an average $64.64 ($1,050,327)
- 4 Open-market sale Chief Business Development Off sold 16,250 shares at an average $64.64 ($1,050,381)
- 4 Grant or award Director acquired 1,504 shares (grant or award)
- 4 Open-market sale Director sold 2,000 shares at $65.45 ($130,900)
- 4 Grant or award Director acquired 1,504 shares (grant or award)
- 4 Grant or award Director acquired 1,504 shares (grant or award)
- 4 Open-market sale Director sold 6,000 shares at $65.08 ($390,480)
- 4 Open-market sale President sold 30,000 shares at an average $63.12 ($1,893,554)
Page 15 of 28 · 544 filings